Sign up for the QMED & MD+DI Daily newsletter.
Hoya’s Pentax Medical to Open Manufacturing, R&D, Service Center in China
The Shanghai facility will focus on the company’s endoscopic products and be dedicated to the China market.
July 10, 2023
1 Min Read
Danai Jetawattana / iStock via Getty Images
Pentax Medical, a division of Hoya Group, today announced the establishment of a manufacturing, research and development, and service center in Shanghai, China. The facility will focus on the company’s endoscopic products and services and be dedicated to the China market under Pentax Medical Shanghai.
The China facility will add to already established R&D centers in Japan, United States, and Germany as the company strives to “enhance customer experience” through customer care and quickly resolving inquiries. The additional facility will, according to the company, allow for closer interaction between stakeholders and R&D.
“We have already established R&D center in Japan, US and Germany to take customers' voices into our R&D activities,” said Rainer Burkard, global president, Pentax, and company president – medtech and life science company, Hoya Corporation, in a press release announcing the facility. “This establishment will allow and cater for closer interaction with the clinical stakeholders and our R&D in China as well."
Additionally, Pentax will be contributing to the country’s “Healthy China” initiative by locally manufacturing high tech medical devices.
"This is a great milestone in Pentax Medical history to add a substantial local facility in China to produce, deliver, and repair innovative endoscopic solutions for medical institutions in China,” said Maha Guruswamy, president, Pentax Asia Pacific region. “This will speed up delivery of Pentax Medical's innovative endoscopic solutions to support enhancement of quality of care in China more than ever.”
Currently, there is no word on a specific site location for the new facility, a timeframe in which it will be built, the projected construction costs, and miscellaneous costs associated to the build.
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read